Randomized Clinical Trial To assess the effecacy of Aragwadhadi taila in comparison with betadine liquid in management of Dushta vrana

Phase 2/3

Not yet recruiting

• Conditions: Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DUSHTAVRANAH,

• Registration Number: CTRI/2022/07/044160
• Lead Sponsor: DR AMRUTA ARVIND NARKAR

Brief Summary

aim of the study will be to give ayurvedic treatment to diseased patient to improve his / her condition and we can give his / her cheap, safe side effect free management. The trial will be conducted on 60 patients for follow up of 0,5,10,15 days and doses of drug as per required once a day for 15 days with 4 follow up (0,5,10,15 days )

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-07-19
• Study Start: 2022-07-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1.Patients having sign and symptoms of Dushta Vrana i.e.infected wound. 2.Dushta Vrana size up to 5×5cms (LxB) 3.Patients of either sex will be selected. 4.The patients of age group 19.

Exclusion Criteria

• 1.Anaemic patient Hb < 10 gm 2.Malnourished patient (as per age, height and weight proportion) 3.Bleeding disorders (increased B.T and C.T) 4.Patient with septicemia 5.The patients suffering from systemic disease such as AIDS, Tuberculosis, Uncontrolled Diabetes mellitus, Hepatitis-B, Malignancy, Vericose ulcer, Deep vein thrombosis, Neurogenic ulcer, Leukemia, etc.
• 6.Any congenital diseases or abnormalities.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1)Dushta vrana (infected wound) has been explained as a stage of vrana in many classical texts. Also, Dushta vrana (infected wound) has been mentioned as a type of vrana (wound).	15 Days of study (0,5,10,15 days)
2)To evaluate the eshtablish safer, cost-effective aragwadhadi taila in the management of dushta vrana (infected wound)	15 Days of study (0,5,10,15 days)

Secondary Outcome Measures

Name	Time	Method
Aragwadhadi Taila is effective management of dushta vrana	15 days of study (0,5,10,15)

Trial Locations

Locations (1)

DR AMRUTA ARVIND NARKAR; 🇮🇳 Pune, MAHARASHTRA, India

DR AMRUTA ARVIND NARKAR

🇮🇳Pune, MAHARASHTRA, India

DR AMRUTA ARVIND NARKAR

Principal investigator

9967111390

narkaramruta13@gmail.com